Concurrent chemotherapy and radiotherapy for advanced non-small-cell lung cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6)1993.
Article
Dans Chinois
| WPRIM
| ID: wpr-679110
ABSTRACT
0.05), especially the survival rate of stage ⅢA disease.Conclusions Concurrent chemoradiotherapy seems to be better than the sequential counter part for NSCLC,without 3 increasing the toxicity.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Radiation Oncology
Année:
1993
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS